Shopping News / Articles
markets. businessinsider. com
markets. businessinsider. com > news > stocks > dar-bioscience-initiates-phase-2-study-of-dare-hpv-a-novel-pharmacologic-treatment-for-persistent-high-risk-hpv-infection-with-no-fda-approved-therapies-1036171242

Dar" Bioscience Initiates Phase 2 Study of DARE-HPV, a Novel Pharmacologic Treatment for Persistent High-Risk HPV Infection with No FDA-Approved Therapies

1+ week, 9+ hour ago  (343+ words) Each year, an estimated six million women in the United States acquire a high-risk HPV infection " and there are no FDA-approved treatments DARE-HPV development is backed by a $10 million U. S. government (ARPA-H)-funded contract; topline data readout expected in 2027 DARE-HPV is…...

Symbols: btc-usd
Medium
medium. com > big-list-energy > 5-reasons-anti-vaxxers-are-so-wrong-1f5f55faad62

5 Reasons Anti-Vaxxers are So Wrong

2+ hour, 50+ min ago  (37+ words) And one reason that might actually make sense I hesitate to start off this diatribe with the hackneyed phrase, "When I was a kid" but it's so relevant I...

USA Today
usatoday. com > press-release > story > 32054 > moderna-announces-new-england-journal-of-medicine-publication-of-pivotal-phase-3-clinical-safety-and-efficacy-data-for-its-investigational-seasonal-influenza-vaccine-mrna-1010

Moderna Announces New England Journal of Medicine Publication of Pivotal Phase 3 Clinical Safety and Efficacy Data for Its Investigational Seasonal Influenza Vaccine, m RNA-1010

2+ week, 5+ day ago  (433+ words) Regulatory filings are under review in the U. S. , Europe, Canada and Australia, with potential approvals expected to begin in 2026 CAMBRIDGE, MA / ACCESS Newswire / May 6, 2026 / Moderna, Inc. Moderna Announces New England Journal of Medicine Publication of Pivotal Phase 3 Clinical Safety and Efficacy…...

Symbols: nasdaq:mrna
Dr. Rich Swier
drrichswier. com > 05/25/2026 > my-submission-to-the-fda-re-vaccines

My Submission to the FDA re Vaccines

10+ hour, 33+ min ago  (492+ words) I was notified by a friend that an FDA advisory committee was accepting public comments (until midnight, Tuesday, the 26th of May, 2026) on vaccine...

NPR
npr. org > 05/20/2026 > nx-s1-5828300 > a-virologist-shares-the-history-and-challenges-of-developing-an-ebola-vaccine

A virologist shares the history (and challenges) of developing an Ebola vaccine

5+ day, 6+ hour ago  (354+ words) NPR's Scott Detrow talks with virologist Dr. Thomas Geisbert about the vaccine used in the Ebola outbreak of 2014 and the challenges for developing a vaccine for this current health emergency. Ebola deaths are rising in East Africa. The World Health…...

The Asahi Shimbun
asahi. com > ajw > articles > 16052799

Halal concerns drive vaccine hesitancy as Indonesia fights measles outbreak | The Asahi Shimbun: Breaking News, Japan News and Analysis

20+ hour, 48+ min ago  (780+ words) September 26, 2025 at 14: 05 JST SUMENEP, Indonesia--Three health care workers rode motorbikes into the Indonesian city of Sumenep, carrying doses of measles vaccine and a list of children who needed them. With blue medical boxes in hand, they went from house…...

markets. businessinsider. com
markets. businessinsider. com > news > stocks > invivyd-and-collaborators-author-new-manuscript-evaluating-early-tolerability-of-covid-monoclonal-antibody-and-comparing-results-to-covid-vaccination-1036136977

Invivyd and Collaborators Author New Manuscript Evaluating Early Tolerability of COVID Monoclonal Antibody and Comparing Results to COVID Vaccination

2+ week, 10+ hour ago  (730+ words) Invivyd and Collaborators Author New Manuscript Evaluating Early Tolerability of COVID Monoclonal Antibody and Comparing Results to COVID Vaccination - Invivyd authors evaluated early side effects of prior low-dose investigational monoclonal antibody adintrevimab from the EVADE study, demonstrating minimal tolerability issues…...

Symbols: nasdaq:ivvd,covid-19
Free Press Journal
freepressjournal. in > pune > jalgaon-mard-and-gmc-organise-free-hepatitis-b-vaccination-drive-for-resident-doctors

Jalgaon: MARD And GMC Organise Free Hepatitis-B Vaccination Drive For Resident Doctors

14+ hour, 7+ min ago  (50+ words) Doctors working in hospitals remain constantly exposed to patients, blood samples, and bodily fluids, placing them at a higher risk of contracting serious infections such as Hepatitis B. Recognising this occupational risk, the vaccination camp was organised to ensure better protection…...

Principia Scientific
principia-scientific. com

NIAID Launched Program Targeting Hantaviruses Before Outbreak | Principia Scientific, Intl.

16+ hour, 59+ min ago  (513+ words) Written by Jon Fleetwood on May 25, 2026. Posted in Current News PROVIDENT remains active through 2029 and had just completed unprecedented Andes hantavirus mapping before the 2026 outbreak emerged The project is run by Dr. Kartik Chandran, a professor at Albert Einstein College…...

Post and Courier
postandcourier. com > health > federal-health-department-withdraws-controversial-vaccine-panel-changes > article_d694ded6-2132-42b1-ba75-d78d5e732226. html

Federal health department withdraws controversial vaccine panel changes

19+ hour, 41+ min ago  (292+ words) U. S. Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr. discusses the findings of the Centers for Disease Control and Prevention's (CDC) latest Autism and Developmental Disabilities Monitoring (ADDM) Network survey, during a press conference at the Department of Health and Human…...

Shopping

Please enter a search for detailed shopping results.